|
|
||||||||
RESEARCH REPORT |
1 School of Dentistry,
2 School of Biomedical Sciences, and
3 Institute for Molecular Bioscience, University of Queensland, St. Lucia, Brisbane, Queensland 4072, Australia;
4 Edison Biotechnology Institute; and
5 Department of Biomedical Sciences, College of Osteopathic Medicine, Ohio University, Athens, OH, USA;
* corresponding author, j.smid{at}mailbox.uq.edu.au
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: cementum growth hormone GH transgenic mice GH receptor knockout mice
| INTRODUCTION |
|---|
|
|
|---|
There is evidence that growth hormone (GH) influences cementogenesis. Rats given daily injections of GH for many months develop molar tooth hypercementosis (Becks et al., 1948). Humans with pituitary gigantism display premature tooth eruption and hypercementosis (Schour and Massler, 1943), whereas those suffering pituitary dwarfism or GH insensitivity, Laron syndrome (LS), display hypodontia and delayed tooth eruption (Sarnat et al., 1988). There are no clinical observations on the cementum of these patients. A reduction in cellular cementogenesis is found in the molar teeth of hypophysectomized rats (Clayden et al., 1994), and this is ameliorated by injections of GH (Clayden et al., 1994; Li et al., 2001). Cementoblasts within cellular cementum display strong reactivity for GH receptor antibody, whereas cementocytes and cementoblasts associated with acellular cementum are negative or react poorly with GH receptor antibody (Zhang et al., 1992). Bone morphogenetic proteins (BMPs) -2 and -4 strongly up-regulate the expression of mineralization genes in cementoblasts (Saygin et al., 2000). In cementoblasts, GH increases the expression of BMP-2 and -4 and bone-related proteins, osteocalcin (OC) and osteopontin (OP) (Li et al., 2001). GH also up-regulates the expression of OC and OP in cellular cementoblasts, but not in cells contributing to acellular cementum (Li et al., 2001).
Several lines of mice have been genetically engineered to produce alterations in the growth hormone (GH) axis (Kopchick et al., 1999). These include the classic giant mouse carrying a bovine GH (bGH) transgene driven by the mouse metallothionein-I (MT) promoter (MT-bGH), leading to excess GH secretion (Kopchick et al., 1999). Another line of bGH transgenic mice carries a (bGH-G119K) transgene in which lysine 119 is substituted for glycine 119 (Chen et al., 1991b). This is a GH antagonist, so these mice are dwarfs (Chen et al., 1991a). In a third line, the GH receptor gene is disrupted or knocked out (GHR-KO), resulting in pronounced dwarfism (Zhou et al., 1997). These three mouse lines represent models for human pituitary gigantism, pituitary dwarfism, and GH insensitivity dwarfism, respectively. Notwithstanding that the first GH transgenic mouse was developed two decades ago, there are no published studies of the dentition in GH transgenic animals. Accordingly, this study compares the amount of cementum in the lower first molar teeth in these three mouse models of altered GH status (MT-bGH, bGH-G119K, and GHR-KO), using morphometric analysis.
| MATERIALS & METHODS |
|---|
|
|
|---|
To study the GH excess condition, we used matched Wt and GHXs mice, with 6 males and 4 females for each phenotype. For the GH antagonist condition, matched Wt and GHAnt mice were used, with 4 males and 6 females for each phenotype. The GHR-KO consisted of Wt, Het, and Homozygous KO groups, and compared 5 males and 5 females for each phenotype (Table
). All mice were killed at 45 days after birth. Prior to death, the mice were weighed, and the nose-rump body length was measured.
|
Tissue Preparation
Mouse heads were bisected sagittally and fixed in 4.0% paraformaldehyde in phosphate-buffered saline (PBS) for 24 hrs at 4°C. The left half-heads were then washed twice in PBS and demineralized (confirmed by radiography) in a neutral EDTA solution. Mandibular molar teeth blocks were then dissected from the left half-heads, trimmed, and embedded in paraffin wax. The molar blocks were embedded on their lingual surfaces. Five-µm-thick serial longitudinal sections with a mesio-distal aspect were cut with a microtome, with the use of ice-cold paraffin blocks. All sections were mounted on aminopropyltriethoxysilane (APES)-coated glass slides. Sections were then stained with hematoxylin and eosin.
Morphometric Analysis
Stained sections were selected for morphometric analysis of the cementum of the first mandibular molar tooth. Ideal sections for analysis included both first molar tooth roots in longitudinal section (see Fig. 1A
). However, even with a stringent alignment of the tissue block, small variations in relative directions of the roots of the first molar tooth meant that the complete section of only one root was generally visible in a given section. Two section selection criteria were used for morphometric analysis: (1) a continuous pulp chamber lumen from the apical foramen to the pulp cavity of the tooth crown, and (2) a cementum layer, continuously visible from the gingival sulcus to the apical foramen. Either one (ideal) or two representative sections (one mesial and one distal root) were taken for morphometric analysis from each molar tooth block.
|
Cellular cementum cross-sectional areas (C, Fig. 1A
), cellular cementum lengths (
to *, Fig. 1A
), and acellular cementum lengths (* to #, Fig. 1A
) were measured for both mesial and distal first mandibular molar tooth roots for each mouse. Measurements were made, on screen images of the selected stained sections, with the use of a morphometric analysis program (Scion Image, Scion Corporation, Frederick, MD, USA). The cementum morphometric data were analyzed statistically (ANOVA) with a statistics program (Minitab12, Minitab Inc., State College, PA, USA).
| RESULTS |
|---|
|
|
|---|
Sections of molar teeth from each group of mice clearly demonstrated qualitative differences in the amount of cementum present on roots of the various teeth (Fig. 1
).
Morphometric analysis revealed that the area of cellular cementum for the lower first molar mesial root (combined mesial areas labeled "C" in Fig. 1A
) of Wt mice is approximately 0.1 mm2 (Fig. 2
); however, this area in bGH-G119K (C57BL/6J strain) Wt mice was slightly larger (Fig. 2
). The presence of the bGH transgene markedly increased the area of cellular cementum, for both the mesial and distal roots (Fig. 2A
). Conversely, the GH antagonist transgene significantly decreased cellular cemental area on both molar roots (Fig. 2B
). In the absence of a functioning GH receptor (GHR-KO), the decrease in cellular cementum area was dramatic, for both mesial and distal roots (Fig. 2C
).
|
|
| DISCUSSION |
|---|
|
|
|---|
Growth hormone appears to affect cellular cementum to a greater degree than acellular cementum (Fig. 3
). There are marked differences between acellular and cellular cementum. Immunohistochemical studies of rat molar tissues show that acellular cementum is strongly immunoreactive for OP (Bronckers et al., 1994; Hashimoto et al., 2001), but it is weakly immunoreactive or negative for OC (Bronckers et al., 1994; Hashimoto et al., 2001; Li et al., 2001). In contrast, cellular cementum is strongly immunoreactive for OC (Li et al., 2001; Sasano et al., 2001), but only moderately so for OP (Hashimoto et al., 2001; Li et al., 2001). A feature of the disease cleidocranial dysostosis (CCD) is teeth which lack of cellular cementum, but have essentially normal acellular cementum (Fukuta et al., 2001). CCD is a genetic disease which arises from mutations in core-binding factor-1 (Cbfa1) gene (Ducy, 2000). This transcription factor, Cbfa1, normally activates the expression of several genes, including the OC gene (Ducy, 2000).
One reason for the unusual sensitivity of cementum to GH may be that cementum is deposited on mouse molar roots at the time of maximum GH effect, that is, after 20 days of post-natal age (Cohn, 1957; Lezot et al., 2000). Based on our previous ultrastructural study (Clayden et al., 1994), GH increases both cementoblast number and secretory activity. This is a particularly strong response, since only 10 days of GH treatment are sufficient to restore cementum to control levels in hypophysectomized rats (Clayden et al., 1994). Cementoblasts display GH receptor immunoreactivity, and cementoblasts which are most active in matrix formation possess the highest GHR immunoreactivity (Zhang et al., 1992). This observation indicates a direct role for GH in promoting cementum formation, but does not exclude the intermediacy of IGF-1 (either endocrine or paracrine in origin). Indeed, we have also showed that immunoreactive IGF-1 receptors are present on cementoblasts (Ong et al., 2001).
The increased number of cementoblasts observed after hGH treatment of hypophysectomized rats suggests an effect of GH on differentiation to cementoblasts (Clayden et al., 1994). This may involve the intermediacy of BMPs-2 and -4, since we have showed that GH is able to induce both of these odontogenic BMPs in periodontal ligament fibroblasts in vitro (Li et al., 1998) and in the periodontium of GH-deficient rats (Li et al., 2001). BMP-2 was recently reported to induce dental follicle cells to differentiate toward a cementoblast phenotype in vitro (Zhao et al., 2002). The increased number of cementoblasts may also be the result of GH-induced proliferation of stem cells in the dental follicle. GH treatment of GH-deficient dwarf rats causes a marked increase in proliferation of odontogenic mesenchyme within the lingual aspect of the rat dental organ, where cementoblast precursors occur (Young et al., 1993). The combined action of GH to promote precursor proliferation and differentiation, together with enhanced matrix secretion by mature cementoblasts, would account for the striking action of GH in promoting cementogenesis.
| ACKNOWLEDGMENTS |
|---|
Received April 16, 2003; Last revision September 17, 2003; Accepted September 23, 2003
| REFERENCES |
|---|
|
|
|---|
Bosshardt DD, Selvig KA (1997). Dental cementum: the dynamic tissue covering of the root. Periodontol 2000 13:4175.
Bronckers AL, Farach-Carson MC, Van Waveren E, Butler WT (1994). Immunolocalization of osteopontin, osteocalcin, and dentin sialoprotein during dental root formation and early cementogenesis in the rat. J Bone Miner Res 9:833841.[ISI][Medline]
Chen WY, White ME, Wagner TE, Kopchick JJ (1991a). Functional antagonism between endogenous mouse growth hormone (GH) and a GH analog results in dwarf transgenic mice. Endocrinology 129:14021408.[Abstract]
Chen WY, Wight DC, Mehta BV, Wagner TE, Kopchick JJ (1991b). Glycine 119 of bovine growth hormone is critical for growth-promoting activity. Mol Endocrinol 5:18451852.[Abstract]
Cho MI, Garant PR (2000). Development and general structure of the periodontium. Periodontol 2000 24:927.
Clayden AM, Young WG, Zhang CZ, Harbrow D, Romaniuk K, Waters MJ (1994). Ultrastructure of cementogenesis as affected by growth hormone in the molar periodontium of the hypophysectomized rat. J Periodontal Res 29:266275.[ISI][Medline]
Cohn SA (1957). Development of the molar teeth in the albino mouse. Am J Anat 101:295319.[ISI][Medline]
Ducy P (2000). Cbfa1: a molecular switch in osteoblast biology. Dev Dyn 219:461471.[ISI][Medline]
Eckstein F, Lochmuller EM, Koller B, Wehr U, Weusten A, Rambeck W, et al. (2002). Body composition, bone mass and microstructural analysis in GH-transgenic mice reveals that skeletal changes are specific to bone compartment and gender. Growth Horm IGF Res 12:116125.[ISI][Medline]
Fukuta Y, Totsuka M, Fukuta Y, Takeda Y, Yoshida Y, Niitsu J, et al. (2001). Histological and analytical studies of a tooth in a patient with cleidocranial dysostosis. J Oral Sci 43:8589.[Medline]
Hashimoto F, Kobayashi Y, Kobayashi ET, Sakai E, Kobayashi K, Shibata M, et al. (2001). Expression and localization of MGP in rat tooth cementum. Arch Oral Biol 46:585592.[ISI][Medline]
Knapp JR, Chen WY, Turner ND, Byers FM, Kopchick JJ (1994). Growth patterns and body composition of transgenic mice expressing mutated bovine somatotropin genes. J Anim Sci 72:28122819.[Abstract]
Kopchick JJ, Bellush LL, Coschigano KT (1999). Transgenic models of growth hormone action. Annu Rev Nutr 19:437461.[ISI][Medline]
Lezot F, Davideau JL, Thomas B, Sharpe P, Forest N, Berdal A (2000). Epithelial Dlx-2 homeogene expression and cementogenesis. J Histochem Cytochem 48:277284.
Li H, Bartold PM, Zhang CZ, Clarkson RW, Young WG, Waters MJ (1998). Growth hormone and insulin-like growth factor I induce bone morphogenetic proteins 2 and 4: a mediator role in bone and tooth formation? Endocrinology 139:38553862.
Li H, Bartold PM, Young WG, Xiao Y, Waters MJ (2001). Growth hormone induces bone morphogenetic proteins and bone-related proteins in the developing rat periodontium. J Bone Miner Res 16:10681076.[ISI][Medline]
Ong CK, Joseph BK, Waters MJ, Symons AL (2001). Growth hormone receptor and IGF-I receptor immunoreactivity during orthodontic tooth movement in the prednisolone-treated rat. Angle Orthod 71:486493.[ISI][Medline]
Sarnat H, Kaplan I, Pertzelan A, Laron Z (1988). Comparison of dental findings in patients with isolated growth hormone deficiency treated with human growth hormone (hGH) and in untreated patients with Laron-type dwarfism. Oral Surg Oral Med Oral Pathol 66:581586.[ISI][Medline]
Sasano Y, Maruya Y, Sato H, Zhu JX, Takahashi I, Mizoguchi I, et al. (2001). Distinctive expression of extracellular matrix molecules at mRNA and protein levels during formation of cellular and acellular cementum in the rat. Histochem J 33:9199.[ISI][Medline]
Saygin NE, Giannobile WV, Somerman MJ (2000). Molecular and cell biology of cementum. Periodontol 2000 24:7398.
Schour I, Massler M (1943). Endocrines and dentistry. J Am Dent Assoc 30:595603.
Young WG, Zhang CZ, Li H, Lobie PE, Waters MJ (1993). A bromodeoxyuridine immunocytochemical and morphometric study of the influence of growth hormone on cell proliferation in odontogenic mesenchyme of the Lewis dwarf rat. Arch Oral Biol 38:207214.[ISI][Medline]
Zhang CZ, Young WG, Li H, Clayden AM, Garcia-Aragon J, Waters MJ (1992). Expression of growth hormone receptor by immunocytochemistry in rat molar root formation and alveolar bone remodeling. Calcif Tissue Int 50:541546.[ISI][Medline]
Zhao M, Xiao G, Berry JE, Franceschi RT, Reddi A, Somerman MJ (2002). Bone morphogenetic protein 2 induces dental follicle cells to differentiate toward a cementoblast/osteoblast phenotype. J Bone Miner Res 17:14411451.[ISI][Medline]
Zhou Y, Xu BC, Maheshwari HG, He L, Reed M, Lozykowski M, et al. (1997). A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Proc Natl Acad Sci USA 94:1321513220.
This article has been cited by other articles:
![]() |
J.R. Smid, J.E. Rowland, W.G. Young, K.T. Coschigano, J.J. Kopchick, and M.J. Waters Mouse Molar Dentin Size/Shape is Dependent on Growth Hormone Status J. Dent. Res., May 1, 2007; 86(5): 463 - 468. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. O. Ramirez-Yanez, J. R. Smid, W. G. Young, and M. J. Waters Influence of growth hormone on the craniofacial complex of transgenic mice Eur J Orthod, October 1, 2005; 27(5): 494 - 500. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.D. Bosshardt Are Cementoblasts a Subpopulation of Osteoblasts or a Unique Phenotype? J. Dent. Res., May 1, 2005; 84(5): 390 - 406. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| IADR Journals | Advances in Dental Research ® |
| Journal of Dental Research ® | Critical Reviews (1990-2004) |